• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Publication

Article

September 20, 2016

Pharmacy Times

September 2016 Men's Health
Volume82
Issue 9

Legal Duty to Preserve Evidence of a Dispensing Error?

Author(s):

Joseph L. Fink III, BSPharm, JD

When the spouse of a patient discovers 2 dosage forms with different appearances in the same medication vial and returns them to the pharmacy, is there a legal duty to preserve the vial and its contents as potential evidence in a yet-to-be-filed malpractice case?

ISSUE OF THE CASE

When the spouse of a patient discovers 2 dosage forms with different appearances in the same medication vial and, suspecting a dispensing error, returns them to the pharmacy, where an incident report is completed and submitted, is there a legal duty to preserve the vial and its contents as potential evidence in a yet-to-be-filed malpractice case?

FACTS OF THE CASE

A prescription for valsartan was presented at a chain pharmacy in a western state. Something went awry, and the vial given to the patient contained valsartan tablets and lithium capsules, medications that have the same color but different shapes. Instructed to take 1 unit of medication per day, the patient consumed as much as 1 lithium capsule for 5 days before his spouse noticed the inconsistent appearance of the contents of the vial. The spouse returned the vial and its contents to the pharmacy, where the pharmacist verified the erroneous lithium in the container by checking its appearance in the pharmacy’s computer database.

The patient began to experience weakness and numbness in his left hand, so he went to an emergency department, the records of which stated that the patient had potentially consumed one 300-mg lithium capsule per day for 5 days. This eventually led to referral to a hand specialist, who performed surgery on the patient.

Slightly more than a year after the prescription had been dispensed, the patient filed suit against the pharmacy chain. As part of the pretrial process of discovery, in which each side has the opportunity to request information from the other to assess what is at issue and the strength of the other side’s case, the patient/plaintiff requested copies of the chain’s policies covering erroneously dispensed prescriptions and handling of returned medications. The chain was requested to turn over the vial and its contents so the plaintiff could have the medications tested. At that point, the defendant/pharmacy notified the plaintiff that the container and its contents had been destroyed pursuant to company policy.

In response, the plaintiff/patient submitted a motion to the court for sanctions, most likely monetary, to be applied to the defendant/pharmacy for what is known legally as “spoliation of evidence.” Spoliation includes destruction or significant alteration of evidence, or the failure to preserve property for use by another as evidence for pending or reasonably foreseeable litigation.

THE COURT’S RULING

The trial court judge denied the plaintiff’s motion seeking sanctions against the defendant pharmacy.

THE COURT’S REASONING

As a point of departure, the court started with the general rule that “a party to a lawsuit must preserve evidence it knows or should know is relevant to a claim or defense of any party, or that may lead to the discovery of relevant evidence.” So, a key portion of that is the notice on the part of the person destroying the item that the thing is potentially relevant to litigation and that knowledge must exist before the thing was destroyed.

The court looked at the internal operating policies of the pharmacy chain. If the potential evidence was destroyed according to the firm’s policies and the defendant doing the destruction had no notice of the potential relevance of the evidence in future litigation, the requirements of spoliation have not been met.

The court concluded that the operating policies had indeed been followed. However, another policy that also was followed was that the firm notified its insurance company of a potential claim when the incident report was submitted. That clearly indicated that the defendant pharmacy was on notice of a potential lawsuit.

The court also looked at whether the alleged spoliation was prejudicial to the plaintiff/patient. In this instance, the court reviewed the evidence available to the plaintiff indicating what medication was erroneously in the bottle, and the maximum amount consumed by the patient. This came from the patient’s medical records, the pharmacy firm’s admissions during depositions, and the testimony of the pharmacist who received the vial from the spouse. All that taken together was sufficient to support the defendant’s case; having the actual container and contents would not add anything more of value.

Emphasizing that the decision to impose sanctions for failing to preserve evidence is discretionary with the court, the judge concluded that the plaintiff/patient had all the information necessary to proceed. The application of sanctions for spoliation was not appropriate in this situation.

Dr. Fink is a professor of pharmacy law and policy and the Kentucky Pharmacists Association Endowed Professor of Leadership at the University of Kentucky College of Pharmacy, Lexington.

Articles in this issue

Easing the Minds of Parents 1 EpiPen at a Time
Easing the Minds of Parents 1 EpiPen at a Time
Improving Asthma Management with Tools and Devices
Improving Asthma Management with Tools and Devices
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient Care
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient Care
Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) Management
Pharmacists on the Multidisciplinary Team: Implementing Best Practices in Chemo-Induced Nausea and Vomiting (CINV) Management
Case Studies (September 2016)
Case Studies (September 2016)
Can You Read These Rxs? (September 2016)
Can You Read These Rxs? (September 2016)

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Related Content
Advertisement
Human fills a prior authorization form - Image credit: Maksim Shchur | stock.adobe.com
August 20th 2025

Alaska Law Implements Time Limits for Prior Authorization Decisions on Medication Coverage

Jim Ruble, PharmD, JD
Focused Female Scientist Examining Digital Data Screen in Modern Laboratory | Image Credit: sarayut | stock.adobe.com
August 20th 2025

Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Blood pressure measuring - Image credit: grinny | stock.adobe.com
August 20th 2025

Arbli From Scienture

Monica Holmberg, PharmD, BCPS
Professional pharmacists working together in modern drugstore | Image Credit: New Africa | stock.adobe.com
August 20th 2025

Adapting Oncology Pharmacy to the Age of AI and Drug Shortages

Alana Hippensteele, Lead Editor
Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists
August 20th 2025

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists

Alana Hippensteele, Lead Editor
White pills with a red exclamation mark symbolize medication safety alert - Image credit: TensorSpark | stock.adobe.com
August 20th 2025

Promote Patient Safety With a Just Culture

Kathleen Kenny, PharmD
Related Content
Advertisement
Human fills a prior authorization form - Image credit: Maksim Shchur | stock.adobe.com
August 20th 2025

Alaska Law Implements Time Limits for Prior Authorization Decisions on Medication Coverage

Jim Ruble, PharmD, JD
Focused Female Scientist Examining Digital Data Screen in Modern Laboratory | Image Credit: sarayut | stock.adobe.com
August 20th 2025

Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Blood pressure measuring - Image credit: grinny | stock.adobe.com
August 20th 2025

Arbli From Scienture

Monica Holmberg, PharmD, BCPS
Professional pharmacists working together in modern drugstore | Image Credit: New Africa | stock.adobe.com
August 20th 2025

Adapting Oncology Pharmacy to the Age of AI and Drug Shortages

Alana Hippensteele, Lead Editor
Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists
August 20th 2025

Navigating Biosimilars and 505(b)(2) Drugs in Oncology: Operational, Clinical, and Policy Strategies for Pharmacists

Alana Hippensteele, Lead Editor
White pills with a red exclamation mark symbolize medication safety alert - Image credit: TensorSpark | stock.adobe.com
August 20th 2025

Promote Patient Safety With a Just Culture

Kathleen Kenny, PharmD
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.